International clinical trial to test the use of dye during children’s cancer surgery
Testing whether a dye called Indocyanine Green (ICG) can help surgeons identify tumours and lymph nodes during surgery.
We have been funding expert research since 2016, aiming to ensure that every child and young person has a safe and effective treatment for their cancer, and that they can live long and happy lives post-treatment.
Testing whether a dye called Indocyanine Green (ICG) can help surgeons identify tumours and lymph nodes during surgery.
Looking for differences in newly diagnosed RMS patient samples to see if there are any that could be used to show whether treatments are working.
A clinical trial testing the use of the 'pink drink' dye in children with brain tumours.
Investigating how antibody immunotherapy causes pain and nerve damage.
Finding which MEK inhibitors work best for children with acute myeloid leukaemia.
Using a new way to measure genetic variation in key sections of noncoding DNA.
Testing nanoparticles as a way of getting drugs where they are needed for acute myeloid leukaemia.
Stopping protein activity to stop anaplastic large cell lymphomas from growing.
Creating antibodies in the lab to treat diffuse midline gliomas and testing their effectiveness.